Marijuana laced with fentanyl, the zombie drug xylazine, and nitazenes were listed as the top concerns people will face in the evolving drug ecosystem, during a Thursday hearing before the House ...

Most states allow some form of "medical marijuana". Medical marijuana is especially popular with pain patients, many of whom ...

Drugmakers offer “copay assistance programs” to help people afford expensive medicines. But health insurers are milking these ...

A group of scientists from the University of Auckland recently studied whether a cancer drug called alpelisib could also slow down aging. Alpelisib is currently used to treat certain types of cancer, ...

Patients taking a commonly used stimulant for the treatment of binge eating disorder experienced mixed results, according to ...

A study on rats found that administering 2,5-dimethoxy-4-iodoamphetamine before giving them an opportunity to take heroin ...

The FDA has approved a new type of painkiller that doesn't come with the risks of addiction and overdose associated with opioids.

Patients seeking an opioid-free way to handle pain experienced in the short-term will soon have a new option.

Suzetrigine, to be sold under the brand name Journavx, is the first new type of pain medicine approved by the FDA in more ...

Suzetrigine prevents pain signals from reaching the brain and doesn't give an opioid-like high, making it non-addictive—but ...

The Food and Drug Administration approved the pill from Vertex Pharmaceuticals for acute pain that often occurs after surgery ...

The drug, Journavx, from Vertex Pharmaceuticals, reduced pain after surgery in clinical trials. Experts hope it can lead to fewer opioid prescriptions.